NIOX Group (LON:NIOX) Stock Breaks Below 200 Day Moving Average Following Insider Selling

Shares of NIOX Group Plc (LON:NIOX) passed below its 200-day moving average during trading on Thursday after an insider sold shares in the company. The stock has a 200-day moving average of GBX 63.07 and traded as low as GBX 60.89. NIOX Group shares last traded at GBX 62.60, with a volume of 847,218 shares trading hands.

Specifically, insider Robert (Rob) Graham Naylor sold 1,639 shares of the firm’s stock in a transaction that occurred on Tuesday, October 27th. The shares were sold at an average price of GBX 80, for a total value of £1,311.20. Also, insider Nicholas Mills sold 4,512 shares of the business’s stock in a transaction on Tuesday, October 27th. The stock was sold at an average price of GBX 80, for a total transaction of £3,609.60. In other news, insider Garry Watts sold 16,545 shares of the company’s stock in a transaction on Tuesday, October 27th. The shares were sold at an average price of GBX 80, for a total transaction of £13,236.

NIOX Group News Summary

Here are the key news stories impacting NIOX Group this week:

• Negative Sentiment: Insiders reported selling a combined 355,277 shares: 161,916 shares on October 27 by several executives, including Jonathan Emms, and 193,361 shares by Ian Johnson on November 2. The disclosed trades were priced at GBX 80 per share. Multiple insider sales could weigh on investor confidence, though their motivation is unknown. NIOX Group insider transactions

NIOX Group Stock Performance

The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.94 and a current ratio of 4.60. The company has a market cap of £263.46 million, a price-to-earnings ratio of 38.40 and a beta of 0.92. The company has a fifty day moving average of GBX 67.18 and a two-hundred day moving average of GBX 63.07.

NIOX Group (LON:NIOX) last issued its quarterly earnings data on Wednesday, September 30th. The company reported GBX 1.41 earnings per share for the quarter. NIOX Group had a return on equity of 10.01% and a net margin of 14.74%. Equities research analysts anticipate that NIOX Group Plc will post 1.17 EPS for the current year.

NIOX Group Company Profile

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.